CN1811388A - Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit - Google Patents
Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit Download PDFInfo
- Publication number
- CN1811388A CN1811388A CN 200610042409 CN200610042409A CN1811388A CN 1811388 A CN1811388 A CN 1811388A CN 200610042409 CN200610042409 CN 200610042409 CN 200610042409 A CN200610042409 A CN 200610042409A CN 1811388 A CN1811388 A CN 1811388A
- Authority
- CN
- China
- Prior art keywords
- add
- rna
- primer
- reverse transcription
- rabbit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a rabbit hemorrhagic disease virus fluorescent quantitative detection method. Said invented technical scheme is characterized by adopting Taqman MGB probe, comparing rabbit hemorrhagic disease virus VP 60 gene, designing a pair of conservative specific primers and a specific MGB probe, and utilizing fluorescent signal to judge rabbit hemorrhagic disease virus.
Description
Technical field: the present invention relates to animal epidemic diagnosis detecting method technical field, is viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit more specifically.
Background technology: rabbit hemorrhagic disease virus has the effect of the blood red blood cell of aggegation people O type, and can be suppressed by corresponding antibody.But because toxic amount is lower in the sick rabbit tissue, be not enough to produce the blood clotting phenomenon, thereby the diagnosis of rabbit hemorrhagic disease virus need carry out the rabbit body earlier and inoculate, do hemagglutination test with the higher liver organization of toxic amount again.So not only wasted time and energy but also delayed treatment time.Conventional PCR method has realized diagnosing fast, delicately the purpose of rabbit hemorrhagic disease virus substantially, but traditional molecular diagnosis method exist complex operation, time-consuming, easy pollution, non-specific height and quantitatively difficulty, be prone to defective such as false positive.
Summary of the invention:, the objective of the invention is to invent a kind of viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit for overcoming above-mentioned shortcoming.Its technical scheme is: 1, design is synthetic and filter out a pair of Auele Specific Primer and specific probe: ForwardPrimer (P1): ACTGGTCGCGGCTGTGAT; Reverse Primer (P2): CCTCCAACCCTGGTCCAAT, fluorescence probe are FAM 5 ' CCACCAGGCATCGA-3 ' MGB; 2, the extraction of RNA (ribonucleic acid) (RNA): in 250 μ l virus concentrate, add 750 μ l lysates, jolting 15s, room temperature is placed 5min; Add 200 μ l chloroforms, jolting 15s; Room temperature is placed 10min; 4 ℃, 10, the centrifugal 15min of 000rpm gets the upper strata water and add the equal-volume isopropyl alcohol in another centrifuge tube, and room temperature is placed 10min behind the mixing; 4 ℃, 12, the centrifugal 12min of 000rpm, precipitated rna; Carefully abandon clean supernatant, with 75% ice-cold ethanol 1ml washing precipitation, behind the suspendible 12, the centrifugal 20min of 000rpm carefully abandons air-dry RNA precipitation in the clean supernatant super-clean bench; Handle water 10 μ l dissolution precipitations with DEPC, and add 1.5 μ l RNA enzyme inhibitors, 5 μ l/ manage packing, frozen or reverse transcription immediately; 3, reverse transcription: will add 2 μ l reverse transcription damping fluids, 0.5 μ l deoxyribonucleotide mixed liquor in each sample of carrying RNA; 0.5 μ l random primer; 0.25 μ l reverse transcriptase adds DEPC water to 10 μ l; 42 ℃ 10~15 minutes, 95 ℃ 2 minutes, reverse transcription becomes cDNA; 4, PCR (PCR): add 25 μ L reaction buffers in each reaction tube, specificity upstream primer and downstream primer respectively add 1ul, probe 2ul; Positive control adds positive plasmid 4ul; ROX confidential reference items 1ul; CDNA adds 4ul; Negative control replaces with deionized water; Add sterile purified water to 50ul; 5, response parameter: 95 ℃ of 10s; 95 ℃ of 5s, 60 ℃ of 31s, 72 ℃ of 10s, 40 circulations; 72 ℃ of 2min; Read fluorescence signal at 60 ℃ of annealing steps of each circulation; Reaction tube packed into start reaction in the quantitative PCR instrument; 6, the result judges: the CT value of positive control should be less than 28, and negative control CT value should be greater than 35; The CT value is smaller or equal to 30, and the tangible amplification of appearance line, shows to have RHDV in the sample, is judged to the positive; The CT value is considered as suspicious between 30-35, answers revision test, if still be judged to feminine gender in this scope.The advantage of this invention is: successfully Auele Specific Primer and probe have been screened in design, have optimized reaction conditions, have successfully drawn typical curve; Utilize this fluorescence quantitative detecting method to solve the diagnosis difficult problem of rabbit hemorrhagic disease, this method can real-time quantitative detects rabbit hemorrhagic disease virus content in the clinical pathological material of disease, and is applicable to the fast detecting of outlet rabbit product.
Embodiment:
One, material:
1. lysate (trizol purchases in reagent company): contain guanidinium isothiocyanate and phenol etc.
2. PCR kit for fluorescence quantitative is purchased the precious biotech firm (Code No:DRR051A) in Dalian: include reverse transcription damping fluid (containing magnesium chloride, Tris-hydrochloric acid, potassium chloride); Four kinds of deoxyribonucleotide mixed liquors; Random primer; Reverse transcriptase; Reaction buffer (containing magnesium chloride, Tris-hydrochloric acid, potassium chloride, archaeal dna polymerase); The RNA enzyme inhibitor; 1%DEPC (burnt ethylene carbonate) water; The ROX reference.
3. reactant liquor (containing Auele Specific Primer 10pmol/ul and probe 5pmol/ul);
Forward?Primer(P1):ACTGGTCGCGGCTGTGAT,
Reverse?Primer(P2):CCTCCAACCCTGGTCCAAT,
Fluorescence probe is FAM 5 ' CCACCAGGCATCGA-3 ' MGB,
4. positive plasmid;
5. chloroform; Isopropyl alcohol; 75% cold ethanol; Fluorescence reaction pipe and lid; 1%DEPC (burnt ethylene carbonate) water.
Two, method of operating:
1. the extraction of RNA (ribonucleic acid) (PNA): in 250 μ l virus concentrate, add 750 μ l lysates, jolting 15s, room temperature is placed 5min; Add 200 μ l chloroforms, jolting 15s.Room temperature is placed 10min; 4 ℃, 10, the centrifugal 15min of 000rpm gets the upper strata water and add the equal-volume isopropyl alcohol in another centrifuge tube, and room temperature is placed 10min behind the mixing; 4 ℃, 12, the centrifugal 12min of 000rpm, precipitated rna; Carefully abandon clean supernatant, with 75% ice-cold ethanol 1ml washing precipitation, behind the suspendible 12, the centrifugal 20min of 000rpm carefully abandons air-dry RNA precipitation in the clean supernatant super-clean bench; Handle water 10 μ l dissolution precipitations with DEPC, and add 1.5 μ l RNA enzyme inhibitors, 5 μ l/ manage packing, frozen or reverse transcription immediately.
2. reverse transcription: will add 2 μ l reverse transcription damping fluids, 0.5 μ l deoxyribonucleotide mixed liquor in each sample of carrying RNA; 0.5 μ l random primer; 0.25 μ l reverse transcriptase adds DEPC water to 10 μ l; 42 ℃ 10~15 minutes, 95 ℃ 2 minutes, reverse transcription becomes cDNA.
3. PCR (PCR): each reaction tube, that is: add 25 μ L reaction buffers in a part, specificity upstream primer and downstream primer respectively add 1ul, probe 2ul; Positive control adds positive plasmid 4ul; ROX confidential reference items 1ul; CDNA adds 4ul; Negative control replaces with deionized water; Add sterile purified water to 50ul.
4. response parameter: 95 ℃ of 10s; 95 ℃ of 5s, 60 ℃ of 31s, 72 ℃ of 10s, 40 circulations; 72 ℃ of 2min.Read fluorescence signal at 60 ℃ of annealing steps of each circulation.Reaction tube packed into start reaction in the quantitative PCR instrument.
5. the result judges: the CT value of positive control should be less than 28, and negative control CT value should be greater than 35;
The CT value is smaller or equal to 30, and the tangible amplification of appearance line, shows to have RHDV in the sample, is judged to the positive;
The CT value is considered as suspicious between 30-35, answers revision test, if still be judged to feminine gender in this scope.
Claims (1)
1, viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit is characterized in that: 1, a pair of Auele Specific Primer of design and probe: Forward Primer (P1): ACTGGTCGCGGCTGTGAT; Reverse Primer (P2): CCTCCAACCCTGGTCCAAT, fluorescence probe are FAM 5 ' CCACCAGGCATCGA-3 ' MGB; 2, the extraction of RNA (ribonucleic acid) (RNA): in 250 μ l virus concentrate, add 750 μ l lysates, jolting 15s, room temperature is placed 5min; Add 200 μ l chloroforms, jolting 15s; Room temperature is placed 10min; 4 ℃, 10, the centrifugal 15min of 000rpm gets the upper strata water and add the equal-volume isopropyl alcohol in another centrifuge tube, and room temperature is placed 10min behind the mixing; 4 ℃, 12, the centrifugal 12min of 000rpm, precipitated rna; Carefully abandon clean supernatant, with 75% ice-cold ethanol 1ml washing precipitation, behind the suspendible 12, the centrifugal 20min of 000rpm carefully abandons air-dry RNA precipitation in the clean supernatant super-clean bench; Handle water 10 μ l dissolution precipitations with DEPC, and add 1.5 μ l RNA enzyme inhibitors, 5 μ l/ manage packing, frozen or reverse transcription immediately; 3, reverse transcription: will add 2 μ l reverse transcription damping fluids, 0.5 μ l deoxyribonucleotide mixed liquor in each sample of carrying RNA; 0.5 μ l random primer; 0.25 μ l reverse transcriptase adds DEPC water to 10 μ l; 42 ℃ 10~15 minutes, 95 ℃ 2 minutes, reverse transcription becomes cDNA; 4, PCR (PCR): add 25 μ L reaction buffers in each reaction tube, specificity upstream primer and downstream primer respectively add 1ul, probe 2ul; Positive control adds positive plasmid 4ul; ROX confidential reference items 1ul; CDNA adds 4ul; Negative control replaces with deionized water; Add sterile purified water to 50ul; 5, response parameter: 95 ℃ of 10s; 95 ℃ of 5s, 60 ℃ of 31s, 72 ℃ of 10s, 40 circulations; 72 ℃ of 2min; Read fluorescence signal at 60 ℃ of annealing steps of each circulation; Reaction tube packed into start reaction in the quantitative PCR instrument; 6, the result judges: the CT value of positive control should be less than 28, and negative control CT value should be greater than 35; The CT value is smaller or equal to 30, and the tangible amplification of appearance line, shows to have RHDV in the sample, is judged to the positive; The CT value is considered as suspicious between 30-35, answers revision test, if still be judged to feminine gender in this scope.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610042409 CN1811388A (en) | 2006-02-23 | 2006-02-23 | Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610042409 CN1811388A (en) | 2006-02-23 | 2006-02-23 | Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1811388A true CN1811388A (en) | 2006-08-02 |
Family
ID=36844433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610042409 Pending CN1811388A (en) | 2006-02-23 | 2006-02-23 | Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1811388A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154512A (en) * | 2011-03-15 | 2011-08-17 | 中国检验检疫科学研究院 | Fluorescence quantitative RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection method for rabbit hemorrhagic disease virus |
CN102251058A (en) * | 2011-07-12 | 2011-11-23 | 广西壮族自治区兽医研究所 | Dual PCR (Polymerase Chain Reaction) quick detection method for rabbit hemorrhagic disease virus and rabbit pasteurellosis |
-
2006
- 2006-02-23 CN CN 200610042409 patent/CN1811388A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154512A (en) * | 2011-03-15 | 2011-08-17 | 中国检验检疫科学研究院 | Fluorescence quantitative RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection method for rabbit hemorrhagic disease virus |
CN102251058A (en) * | 2011-07-12 | 2011-11-23 | 广西壮族自治区兽医研究所 | Dual PCR (Polymerase Chain Reaction) quick detection method for rabbit hemorrhagic disease virus and rabbit pasteurellosis |
CN102251058B (en) * | 2011-07-12 | 2013-03-13 | 广西壮族自治区兽医研究所 | Dual PCR (Polymerase Chain Reaction) quick detection method for rabbit hemorrhagic disease virus and rabbit pasteurellosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11421283B2 (en) | Circulating microRNA as a marker for hepatocellular carcinoma | |
US10036062B2 (en) | Primer middle sequence interference PCR technology | |
Asselah et al. | Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C | |
US20100086481A1 (en) | Differential expression of molecules associated with intra-cerebral hemorrhage | |
CN106967820B (en) | lncRNA gene marker and kit for early diagnosis of primary liver cancer | |
JP2015530092A (en) | Biological sample stabilization | |
Mohy et al. | Role of transforming growth factor-β1 in serum and− 509 C> T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients | |
Aly et al. | Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 gene expression profiles as potential biomarkers in HCV induced hepatocellular carcinoma | |
CN102329888A (en) | Fluorescent quantitative PCR (Polymerase Chain Reaction) testing method for cccDNA (covalently closed circular deoxyribonucleic acid) of hepatitis B virus and kit thereof | |
CN104711344A (en) | Warfarin individualized medication gene detection kit and application thereof | |
CN1811388A (en) | Viral hemorrhagic viruse fluorescence quantitative detecting method for rabbit | |
US20100304988A1 (en) | Diagnostic of immune graft tolerance | |
JP2003527098A (en) | Nucleic acid primers and probes for detecting tumor cells | |
JP2012513757A (en) | Primer and probe for detection of hepatitis C virus | |
US9074247B2 (en) | P53 assay for a urine test for HCC screening | |
WO2019105090A1 (en) | Composition for detecting esophageal cancer and use thereof | |
Dong et al. | Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma | |
CN103013994A (en) | Primer and method for screening nine types of known BCR/ABL fusion genes by using primer | |
CN107177679A (en) | A kind of kit for detecting esophageal squamous cell carcinoma related gene TFPI2 and HSPB2 promoter methylation degree | |
WO2024016461A1 (en) | Bispecific-probe-coupled capture magnetic bead, and preparation method therefor and use thereof | |
JP2014239692A (en) | METHOD FOR PRODUCTION OF cDNA FOR TERT GENE, NUCLEIC ACID AMPLIFICATION METHOD AND DETECTION METHOD USING THE SAME, PRIMER FOR USE IN THE SAME, AND TUMOR DIAGNOSIS KIT USING THE SAME | |
WO2018129886A1 (en) | Primary biliary cholangitis-associated interleukin 16 and application thereof | |
CN112852963B (en) | Detection kit for novel molecular marker tRF-Leu-AAG-007 for liver cancer | |
Eldinc et al. | TLR2 Gene Polymorphism and MicroRNA 301 gene Expression Level as Signatures for Hepatocellular Carcinoma in Egyptian Patients | |
CN114317715B (en) | Application of SNP marker of MBOAT7 in diagnosis of non-obese MAFLD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20060802 |